TNF and periodontal disorder: In agreement to these findings, it has been shown that inhibition of 5LO or its products may contribute to attenuate inflammatory response in a mouse model of of LPS-induced periodontal disease, with reduction of LTB4, TNF and IL-12 levels, attenuation of inflammation, reduced osteoclasts number and consequently, decreased bone resorption48,49.